Pamidronate “zebra lines”: A treatment timeline

Osteogenesis imperfecta is a hereditary bone dysplasia characterized by bone fragility, deformity, and short stature. Treatment focuses on preventing bone fractures and symptom relief. Pamidronate, a second-generation bisphosphonate drug that minimizes bone loss, is the chosen treatment in osteogene...

Full description

Bibliographic Details
Main Authors: Avgi Loizidou, BSc, MBChB, Savvas Andronikou, MBBCh, FCRad, FRCR, PhD, Christine P Burren, MBBS, MD, FRACP, FRCPCH
Format: Article
Language:English
Published: Elsevier 2017-12-01
Series:Radiology Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1930043317301528